Rights and permissions
About this article
Cite this article
Novartis' 2001 consumer health growth largely due to OTC switch products. Pharmacoecon. Outcomes News 350, 12 (2002). https://doi.org/10.1007/BF03278712
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03278712